Fragment-based discovery of JAK-2 inhibitors

被引：69

作者：

Antonysamy, Stephen ^{[1
]}

Hirst, Gavin ^{[1
]}

Park, Frances ^{[1
]}

Sprengeler, Paul ^{[1
]}

Stappenbeck, Frank ^{[1
]}

Steensma, Ruo ^{[1
]}

Wilson, Mark ^{[1
]}

Wong, Melissa ^{[1
]}

机构：

[1] SGX Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 01期

关键词：

Fragment-based design; JAK-2; inhibitors; Structure-based design; Aminoindazole; Kinase inhibitors; MYELOPROLIFERATIVE DISORDERS; JAK/STAT PATHWAY; STATS;

D O I：

10.1016/j.bmcl.2008.08.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fragment-based hit identification coupled with crystallographically enabled structure-based drug design was used to design potent inhibitors of JAK-2. After two iterations from fragment 1, we were able to increase potency by greater than 500-fold to provide sulfonamide 13, a 78-nM JAK-2 inhibitor. (C) 2008 Published by Elsevier Ltd.

引用

页码：279 / 282

页数：4

共 50 条

[1] Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors
Ritzen, Andreas
Sorensen, Morten D.
Dack, Kevin N.
Greve, Daniel R.
Jerre, Anders
Carnerup, Martin A.
Rytved, Klaus A.
Bagger-Bahnsen, Jesper
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (06): : 641 - 646
[2] Fragment-based discovery of 6-arylindazole JAK inhibitors
Ritzen, Andreas
Sorensen, Morten
Dack, Kevin
Greve, Daniel
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[3] Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity
Ritzen, Andreas
Vifian, Thomas
Sindet, Rikke
Hansen, Bettina
Larsen, Mogens
Jepsen, Tue
Larsen, Jens
Seitzberg, Jimmi
Rai, Sanjay
Nasipireddy, Venkatarathnam
Carnerup, Martin
Jerre, Anders
Molck, Christina
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[4] Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype Selectivity
Hansen, Bettina Borreschmidt
Jepsen, Tue Heesgaard
Larsen, Mogens
Sindet, Rikke
Vifian, Thomas
Burhardt, Mia Norreskov
Larsen, Jens
Seitzberg, Jimmi Gerner
Carnerup, Martin A.
Jerre, Anders
Molck, Christina
Lovato, Paola
Rai, Sanjay
Nasipireddy, Venkatarathnam Reddy
Ritzen, Andreas
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (13) : 7008 - 7032
[5] Fragment-Based Approaches to the Discovery of Kinase Inhibitors
Mortenson, Paul N.
Berdini, Valerio
O'Reilly, Marc
PROTEIN KINASE INHIBITORS IN RESEARCH AND MEDICINE, 2014, 548 : 69 - 92
[6] Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors
Svensson, Fredrik
Bender, Andreas
Bailey, David
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1415 - 1424
[7] Fragment-Based Drug Discovery of Novel MK2 Inhibitors
Hesterkamp, Thomas
JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 894 - 895
[8] Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors
Burdick, Daniel J.
Wang, Shumei
Heise, Christopher
Pan, Borlan
Drummond, Jake
Yin, JianPing
Goeser, Lauren
Magnuson, Steven
Blaney, Jeff
Moffat, John
Wang, Weiru
Chen, Huifen
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4728 - 4732
[9] Fragment-based discovery of the first known inhibitors of PHGDH
Fuller, Nathan
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[10] Fragment-based discovery of focal adhesion kinase inhibitors
Graedler, Ulrich
Bomke, Joerg
Musil, Djordje
Dresing, Verena
Lehmann, Martin
Hoelzemann, Guenter
Greiner, Hartmut
Esdar, Christina
Krier, Mireille
Heinrich, Timo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5401 - 5409

← 1 2 3 4 5 →